| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2894136 | Atherosclerosis | 2008 | 9 Pages |
Abstract
These data suggest that chronic inhibition of the RAS by telmisartan prevails in reducing advanced atherosclerosis and promoting plaque stability over ramipril, possibly through the reduced activity of the pro-inflammatory transcription factors NFκB and Egr-1 and through the activation of PPARγ.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Erwin Blessing, Michael Preusch, Roger Kranzhöfer, Ralf Kinscherf, Nikolaus Marx, Michael E. Rosenfeld, Berend Isermann, Christian M. Weber, Jörg Kreuzer, Julia Gräfe, Hugo A. Katus, Florian Bea,